What exactly is Epithalon (AEDG), and why does the sequence matter when buying?
Epithalon is a linear tetrapeptide composed of four amino acid residues in the order Ala-Glu-Asp-Gly, abbreviated AEDG. Because the molecule is short and unmodified (no disulfide bridges, no glycosylation, no complex protecting-group chemistry in the final product), it is amenable to complete analytical characterisation, which is precisely why a buyer can and should demand strong identity data. The literature describes Epitalon as a highly bioactive pineal tetrapeptide of research interest, and its compact structure is central to how it is studied at the molecular level (Araj SK et al, 2025). Regulatory-peptide research has also examined how such short peptides interact at the level of gene transcription and can associate with the DNA double helix, underscoring why unambiguous confirmation of the exact residue sequence — not merely the correct molecular weight — is analytically meaningful (Khavinson VKh et al, 2003; Khavinson V et al, 2005). From a purchasing standpoint, the sequence matters because two impurities are especially relevant for tetrapeptides: truncated sequences (missing a terminal residue) and deletion/insertion variants that can share a similar mass or retention time. A CoA that only quotes 'MW confirmed' without sequence-level or fragment-level evidence leaves those risks unaddressed. When evaluating an Australian source, confirm the product page and batch report state the full AEDG sequence, the theoretical monoisotopic and average masses, and the analytical methods used to establish identity. This gives you a defensible basis for accepting a lot into a research workflow and a reference point for any independent re-testing you commission later.
Which purity data should an Epithalon certificate of analysis include?
The single most important number on an Epithalon CoA is the reversed-phase HPLC purity, expressed as area-percent at a stated detection wavelength (typically UV around 214-220 nm for peptide bonds). For a tetrapeptide, look for the chromatographic method parameters: column chemistry (C18 is common), mobile-phase system, gradient, flow rate and run time. A credible report also states the main-peak area-percent alongside the largest single impurity and total related substances, because a high headline purity number can mask a single co-eluting impurity if peak purity is not assessed. Peak-purity assessment using diode-array detection (DAD) helps confirm that the main peak is spectrally homogeneous rather than two overlapping species. Ask whether the acceptance criterion is defined (for example, a specification limit against which the batch was judged pass or fail) rather than a bare result with no context. Purity alone is not identity: two different compounds can share a retention time, so purity data must be paired with mass-spectrometric confirmation described in the next section. For Australian buyers, the practical checklist is: (1) HPLC area-percent purity with wavelength stated; (2) named largest single impurity and total impurities; (3) evidence of peak-purity/spectral homogeneity; (4) a written specification limit; and (5) the batch/lot number that ties the result to the vial you receive. Reconciling the reported purity against an orthogonal method — for example comparing UV-based HPLC area-percent with mass-spectrometric impurity findings — strengthens confidence that the figure is real and not an artefact of a single technique.
How is Epithalon identity confirmed by mass spectrometry?
Identity confirmation for a tetrapeptide relies on orthogonal mass spectrometry to complement chromatographic purity. Electrospray ionisation (ESI) or MALDI-TOF establishes the molecular weight, and the observed mass should match the theoretical value for AEDG within the instrument's stated accuracy. Because a molecular-weight match alone cannot distinguish sequence isomers, tandem mass spectrometry (MS/MS) that generates fragment ions provides sequence-level evidence — the b- and y-ion series should be consistent with the Ala-Glu-Asp-Gly order. This is particularly relevant for Epithalon because research into regulatory peptides has emphasised the specificity of short-sequence interactions, so confirming the exact residue order rather than just the mass is a reasonable analytical expectation (Khavinson V et al, 2005; Khavinson VKh et al, 2003). Recent Epitalon studies characterising its activity in cell and oocyte models also depend on well-defined, correctly identified material, reinforcing that any research use begins with confirmed identity (Al-Dulaimi S et al, 2025; Ullah S et al, 2025). When reviewing an Australian supplier's batch report, check for: the ionisation method used, the observed versus theoretical mass, the mass-accuracy tolerance, and — ideally — MS/MS fragment mapping or an equivalent sequence-confirmation step. Where a supplier provides HPLC and MS from the same laboratory on the same lot, the two datasets should reconcile: the mass-spec identity should correspond to the main HPLC peak, and any HPLC impurities should have a plausible mass-spec explanation (for example a truncation losing one residue). A report that presents both techniques and explains their agreement is far more useful for procurement than either result in isolation.
What stability, water content and counterion information affects an Epithalon purchase?
Beyond identity and purity, three quality attributes influence how meaningful a purity figure is over time. First, counterion content: synthetic peptides are frequently isolated as trifluoroacetate (TFA) or acetate salts, and the salt fraction affects the true net peptide content by mass. A CoA that reports counterion identity and, ideally, quantifies it lets you correct apparent mass to net peptide content — important when comparing lots or suppliers. Second, water content: lyophilised tetrapeptides are hygroscopic, and residual or absorbed water changes the effective peptide mass. Karl Fischer titration is the standard method for water-content determination, and its inclusion signals a supplier that characterises net content rigorously. Third, stability and storage: short peptides can be susceptible to degradation pathways such as deamidation and oxidation, and Epithalon's glutamate/aspartate residues make deamidation-type chemistry a relevant consideration for characterisation. Ask whether the supplier provides storage and handling guidance for the lyophilised material and whether any stability or forced-degradation data underpin the shelf-life statement. For Australian buyers, local warehousing with tracked dispatch and batch documentation supplied per lot is the practical differentiator — you receive material with a CoA that matches the vial, rather than relying on inference. The composite checklist here is: counterion identified (and quantified where possible), water content by Karl Fischer, net peptide content stated, degradation pathways acknowledged, and clear storage guidance. Together these turn a headline purity percentage into a defensible net-content figure you can plan a research study around.
How do you evaluate an Australian Epithalon supplier before ordering?
Supplier evaluation for research-grade Epithalon in Australia should be evidence-based rather than reputation-based. Start with batch traceability: every vial should carry a lot number that cross-references a specific CoA, and the CoA should be dated, method-specific and lot-specific — not a generic marketing document reused across batches. Confirm the analytical scope matches the checklist above: RP-HPLC purity with stated wavelength and specification, orthogonal mass-spectrometric identity (ideally with sequence-level confirmation), counterion and water content, and net peptide content. A transparent supplier will explain which tests are performed in-house versus by an external laboratory and will make redacted or full batch reports available on request. Consider whether independent confirmation is possible — a supplier confident in its material will not object to you commissioning orthogonal re-testing on the received lot, and being able to reconcile your own HPLC-MS results against the CoA closes the loop. Practical Australian-specific factors include local stock with tracked domestic dispatch and documentation issued per lot, which shortens the chain between manufacture, testing and receipt. Framing matters too: legitimate research suppliers position everything as research-use-only and avoid outcome or usage claims. Treat any vendor making human-use or benefit claims as a compliance red flag. Finally, build a simple internal acceptance record: log the lot number, the CoA date, the reported purity and identity results, the counterion and water content, and any re-testing you perform. This documentation trail is what lets you defend the provenance and quality of the material used in a study long after the order was placed.
Source materials that match this documentation standard
The sections above describe how serious laboratories evaluate identity, purity, and batch records. When you are ready to source research materials against that same standard, ClaraScience supplies from Australian warehouses with Express tracked dispatch and batch documentation on every order.
Retail catalogue orders ship with lot documentation. Qualified buyers can request wholesale portal access for bulk restocks and tier pricing.
Frequently asked questions
Is Epithalon the same as Epitalon?
Yes. 'Epithalon' and 'Epitalon' are common alternative spellings for the same synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). When buying in Australia, match the CoA sequence and molecular-weight data to AEDG regardless of which spelling a supplier uses on the product page (Araj SK et al, 2025).
What purity should an Epithalon certificate of analysis report?
A CoA should report reversed-phase HPLC purity as area-percent at a stated UV wavelength, name the largest single impurity and total related substances, provide evidence of peak-purity/spectral homogeneity, and quote a written specification limit tied to the lot number. Purity must be paired with mass-spectrometric identity to be meaningful.
How is the AEDG sequence confirmed analytically?
Molecular weight is established by ESI or MALDI-TOF mass spectrometry and compared to the theoretical AEDG mass. Because a mass match alone cannot rule out sequence isomers, tandem MS/MS fragment mapping is used to confirm the Ala-Glu-Asp-Gly residue order (Khavinson V et al, 2005).
Why does counterion and water content matter?
Synthetic peptides are often isolated as TFA or acetate salts, and lyophilised material absorbs water. Both add mass, so a CoA reporting counterion identity and Karl Fischer water content lets you calculate net peptide content and compare lots or suppliers on a like-for-like basis.
What makes an Australian Epithalon supplier credible for research use?
Look for per-lot certificates of analysis that cross-reference the vial's lot number, a full analytical scope (HPLC purity plus orthogonal MS identity, counterion and water content), local stock with tracked dispatch, willingness to allow independent re-testing, and strictly research-use-only framing with no benefit or usage claims.
References
- PMID:40141333 — Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Int J Mol Sci — 2025
- PMID:14666197 — Effect of regulatory peptides on gene transcription — Bull Exp Biol Med — 2003
- PMID:15990728 — DNA double-helix binds regulatory peptides similarly to transcription factors — Neuro Endocrinol Lett — 2005
- PMID:40908429 — Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Biogerontology — 2025
- PMID:39788414 — Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development — Life Sci — 2025
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
